老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

2.38
-0.0600-2.46%
盘后：2.390.0100+0.42%19:58 EDT
成交量：12.60万
成交额：30.44万
市值：567.86万
市盈率：-0.01
高：2.50
开：2.45
低：2.36
收：2.44
数据加载中...
总览公司新闻公告
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/12

重要事件披露

8-K - Current report
2021/05/04

重要事件披露

8-K - Current report
2021/05/04

企业合并公告

425 - Prospectuses and communications, business combinations
2021/04/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/12

重要事件披露

8-K - Current report
2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/02/03

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/22

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K - Current report
2021/01/20

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/20

企业合并公告

425 - Prospectuses and communications, business combinations
更多